At first glance, it appears that little will change between now and 2040 when it comes to the types of cancers that people develop and that kill them, a new forecast shows.
Breast, melanoma, lung and colon cancers are expected to be the most common types of cancers in the United States, and patients die most often from lung, pancreatic, liver and colorectal cancers, according to the lates...
Black people with hepatitis C develop liver cancer sooner than people in other racial groups and the cancer is often more aggressive, but current screening guidelines may not be broad enough to catch these cases early, according to a new study.
Why? Despite often being more advanced, liver cancer in Black people is slower to cause liver damage and scarring, and current guidelines call for...
A new drug combination for advanced liver cancer can extend people's lives substantially more than the long-standing drug of choice, new study findings confirm.
The treatment involves two drugs approved to fight various cancers: bevacizumab (Avastin) and atezolizumab (Tecentriq). Avastin, an intravenous (IV) drug, starves tumors by preventing new blood vessel growth.
Breast cancer has surpassed lung cancer as the world's most commonly diagnosed cancer.
In 2020, there were an estimated 19.3 million new cancer cases and nearly 10 million cancer deaths worldwide, according to the Global Cancer Statistics 2020 report from the American Cancer Society (ACS) and the International Agency for Research on Cancer.
Cancer survivors are at greater risk of developing another cancer and dying from it, a new study finds.
These new cancers can result from a genetic predisposition, from treatments such as radiation and chemotherapy used to fight the first cancer, as well as from unhealthy lifestyles such as smoking and obesity, according to researchers from the American Cancer Society.
Scientists are working on a blood test that may catch five common cancers years sooner than current methods.
The blood test, which is still experimental, hunts for certain genetic "signatures" associated with tumors. Researchers found that it can detect five types of cancer -- colon, esophageal, liver, lung and stomach -- up to four years earlier, compared to routine medical care.
After spending much of 2016 healing following the deaths of both his partner of 25 years and his mother, Oswald Peterson -- a professional carnival dancer in New York City -- was convinced 2017 would be his year to start again.
But life had other plans. Peterson, now 53, woke up on New Year's Day 2017 feeling awful.
"I could barely get across the floor. I went to urgent ca...
A 29% drop in U.S. cancer deaths between 1991 and 2017 was driven by declines in deaths from four major cancers -- lung, colon, breast and prostate, according to the latest American Cancer Society (ACS) annual report.
Cancer deaths in the United States fell 2.2% between 2016 and 2017, the largest-ever single-year decrease.
As doctors race to determine what is causing sudden and severe lung illnesses among some vapers, new research discovers dangerously high levels of a known carcinogen in menthol-flavored electronic cigarettes.
The chemical (pulegone) is used as a menthol and mint flavoring, even though it was recently banned in foods, the researchers said.
The popular weed killer Roundup might be linked to liver disease, a new study suggests.
A group of patients suffering from liver disease had elevated urine levels of glyphosate, the primary weed-killing ingredient in Roundup, according to researchers at the University of California, San Diego (UCSD).
"We found those patients who had more severe disease had higher levels of [...
Millions of hepatitis C cases and related deaths could be prevented, but it will require a significant investment, researchers say.
In the first study to model such measures worldwide, the authors concluded that sweeping prevention, screening and treatment efforts could prevent 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths by 2030.
The percentage of U.S. liver transplant recipients with alcohol-associated liver disease (ALD) doubled over 15 years, but significant regional variations remain, a new study finds.
ALD has replaced hepatitis C as the most common reason for U.S. liver transplants. One reason is that hepatitis C rates have decreased due to antiviral therapy. But a more likely cause for the change is the...